Skip to main content
. 2017 Mar 20;52(6):324–333. doi: 10.1097/RLI.0000000000000344

FIGURE 6.

FIGURE 6

A, Eight weeks after the last injection (20 × 2.5 mmol Gd/kg body weight), high Gd concentrations were measured for the linear agents gadodiamide and gadopentetate dimeglumine in the skin and bone. B, The average concentration (mean ± SD) of residual Gd in the brain was approximately 100-fold lower compared with the skin in gadodiamide-injected rats and approximately 15-fold higher for linear than for macrocyclic GBCAs. Low Gd concentrations were measurable when both classes of GBCAs were used.